Thursday, January 22, 2015

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (mHealth) (R21) (PAR-14-028)


This is a reminder that the deadline for the NIH R21 Grant for Mobile Health: Technology and Outcomes in Low and Middle Income Countries is approaching.

Deadlines

Application due date: February 19, 2015

Eligibility

Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution (with LMIC defined by The World Bank as low-, lower-middle-, or upper-middle-income economies).
Program Directors/Principal Investigators may be employed in either a U.S. or LMIC institution, but should plan to build capacity in mHealth research in the LMIC institution(s).
See full Eligibility Information for more details.

Award Budget
Applicants may request up to $125,000 direct costs per year.


Award Project Period
The total project period may not exceed 2 years.

Full Funding Announcement:


http://grants.nih.gov/grants/guide/pa-files/PAR-14-028.html


Program Overview
Mobile Health: Technology and Outcomes in Low and Middle Income Countries will support research on the development or adaptation of mobile health (mHealth) technology specifically suited for low- and middle-income countries (LMICs) and the health-related outcomes associated with implementation of the technology.

The program aims to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area. In the context of this program, mHealth includes the use of mobile and wireless devices (cell phones, tablets, etc.) to improve health outcomes, health care services and health research. The mHealth technology that is developed or adapted in proposed projects can include external hardware and/or software components for mobile or wireless devices.

Of highest interest are well-designed multidisciplinary projects that focus on tools or interventions for chronic diseases or technology for disease agnostic and/or crosscutting applications. See the full program announcement for details on the specific research interests of the participating NIH Institutes and Centers.